Medication safety implications of a technological intervention, v.1

  • Research type

    Research Study

  • Full title

    Medication safety implications of a technological intervention

  • IRAS ID

    147035

  • Contact name

    Denham Phipps

  • Contact email

    denham.phipps@manchester.ac.uk

  • Sponsor organisation

    The University of Manchester

  • Research summary

    The proliferation of information technology has brought with it the potential for advances in the delivery of primary healthcare. Amongst the purposes to which it has been put is medicines safety, with field studies demonstrating that technology-based interventions can reduce the risk of adverse events. However it is also apparent from previous studies that, in order to realise the potential of such interventions, they need to be well-matched with the organisational context within which it is deployed. For example, the way that tasks are organized, allocated and performed should be taken into account when designing and evaluating the intervention.

    The proposed study follows the introduction of an IT system for medicines management to the primary healthcare organisations within one clinical commissioning group (CCG). The aim of the study is to assess the effect of this system on medicines safety activities in a primary care setting. Specific objectives are to:
    - Investigate stakeholder perceptions of the intervention using interviews and focus groups;
    - Examine user interaction with the implemented system during medicines management activities using observations;
    - Identify ways of using the system to best effect in medication safety improvement.

  • REC name

    North West - Preston Research Ethics Committee

  • REC reference

    14/NW/0113

  • Date of REC Opinion

    17 Apr 2014

  • REC opinion

    Further Information Favourable Opinion